Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Mar 4, 2022
Document Date
Mar 1, 2022
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Sepp-Lorenzino Laura